Gyre Therapeutics
GYRE
GYRE
65 hedge funds and large institutions have $59.3M invested in Gyre Therapeutics in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 70 → 65 (-5)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
31% less capital invested
Capital invested by funds: $85.6M → $59.3M (-$26.3M)
Holders
65
Holding in Top 10
1
Calls
$554K
Puts
$401K
Top Buyers
| 1 | +$6.75M | |
| 2 | +$1.82M | |
| 3 | +$1.62M | |
| 4 |
2L
22NW LP
Seattle,
Washington
|
+$1.12M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$820K |
Top Sellers
| 1 | -$4.08M | |
| 2 | -$3.45M | |
| 3 | -$2.44M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$2.05M |
| 5 |
Renaissance Technologies
New York
|
-$1.91M |